Evidence map›Paper›PMID 21220509›Full record

ArticleThe Journal of cell biology2011

Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.

Sean M Hartig, Bin He, Weiwen Long, Benjamin M Buehrer, Michael A Mancini

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. American journal of physiology. Endocrinology and metabolism · 2020
    Article
  11. Bisphenol AF promotes inflammation in human white adipocytes.American journal of physiology. Cell physiology · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sean M HartigMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Bin He
Weiwen Long
Benjamin M Buehrer
Michael A Mancini
Baylor College of Medicine · USTriangle · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 1998 to 2013
$19.9M
REPRODUCTIVE BIOLOGY: REGULATORY MECHANISMST32HD007165 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI O'MALLEY, BERT W · 1985 to 2015
$5.6M
REGULATION OF GENETIC STABILITY BY THE INT6 FAMILYR01CA090464 · NCI · NEW YORK UNIVERSITY · PI CHANG, ERIC C · 2002 to 2011
$2.5M
STEROID RECEPTOR FUNCTION AND NUCLEAR ORGANIZATIONR01DK055622 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MANCINI, MICHAEL A · 1999 to 2007
$2.1M
Androgen Receptor Function in White Adipocyte DevelopmentK01DK081446 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HE, BIN · 2008 to 2010
$344k
Unique Roles of p160 Coactivators during Human AdipogenesisF32DK085970 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2009 to 2010
$102k
NCI NIH HHS 5R01CA090464NCI NIH HHS P30 CA-125123NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA090464NICHD NIH HHS 5T32HD007165NICHD NIH HHS T32 HD007165NICHD NIH HHS U54 HD-007495NICHD NIH HHS U54 HD007495NIDDK NIH HHS 1F32DK85979NIDDK NIH HHS 5K01DK081446NIDDK NIH HHS 5R01DK055622NIDDK NIH HHS F32 DK085970NIDDK NIH HHS K01 DK081446NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK-56338NIDDK NIH HHS R01 DK055622
6 · The paper itself

Abstract

The related coactivators SRC-2 and SRC-3 interact with peroxisome proliferator activated receptor γ (PPARγ) to coordinate transcriptional circuits to promote adipogenesis. To identify potential coactivator redundancy during human adipogenesis at single cell resolution, we used high content analysis to quantify links between PPARγ, SRC-2, SRC-3, and lipogenesis. Because we detected robust increases and significant cell-cell heterogeneity in PPARγ and lipogenesis, without changes in SRC-2 or SRC-3, we hypothesized that permissive coregulator levels comprise a necessary adipogenic equilibrium. We probed this equilibrium by down-regulating SRC-2 and SRC-3 while simultaneously quantifying PPARγ. Individual or joint knockdown equally inhibits lipid accumulation by preventing lipogenic gene engagement, without affecting PPARγ protein levels. Supporting dominant, pro-adipogenic roles for SRC-2 and SRC-3, SRC-1 knockdown does not affect adipogenesis. SRC-2 and SRC-3 knockdown increases the proportion of cells in a PPARγ(hi)/lipid(lo) state while increasing phospho-PPARγ-S114, an inhibitor of PPARγ transcriptional activity and adipogenesis. Together, we demonstrate that SRC-2 and SRC-3 concomitantly promote human adipocyte differentiation by attenuating phospho-PPARγ-S114 and modulating PPARγ cellular heterogeneity.

Indexed as

AdipogenesisHomeostasisAdipocytesCell DifferentiationFemaleGene Expression RegulationGene Knockdown TechniquesHeLa CellsHumansImaging, Three-DimensionalLipogenesisNuclear Receptor Coactivator 2Nuclear Receptor Coactivator 3PhenotypePhosphorylationPPAR gammaNCOA2 protein, humanNCOA3 protein, humanNuclear Receptor Coactivator 2Nuclear Receptor Coactivator 3PPAR gammaRNA, MessengerRNA, Small Interfering

Identifiers

PMID21220509
PMCPMC3019557
OpenAlexW2123835414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.